NIH-funded research R01 grant

Creating a model to study how aging affects disease progression

Official title: Engineered hybrid aging model for disease progression

Funded at University of Notre Dame · NIH-11085256 · Data updated 2026-11-12

This study is looking at how getting older affects diseases like cancer and heart problems, using a special 3D model that mimics older human tissues to help find better treatments for older patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Notre Dame
NIH-funded
Lab location1 site (Notre Dame, United States)
Project startJune 13, 2023
Project endMay 31, 2028
Funding year2025
Award (this year)$462,702
NIH project number5R01CA275423-03
Project IDNIH-11085256 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals aged 65 and older who are at risk for age-related diseases.

Less likely to help

Patients under the age of 65 or those without age-related diseases may not benefit from this research.

What this research studies

This research investigates how the aging process influences the development and progression of diseases like cancer and cardiovascular conditions. By engineering a 3D model that mimics the aged human microenvironment, researchers aim to better understand how age-related changes in tissue affect disease outcomes. The approach involves using decellularized extracellular matrix from aged human tissues and implanting it into mice to study tumor behavior and drug responses. This innovative model could lead to more effective treatments tailored for older patients.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for diseases that disproportionately affect older adults.

How similar studies have gone: Other research has shown promise in using engineered tissue models to study disease, indicating that this approach could yield valuable insights.

Where this research is happening

  • University of Notre Dame
    Notre Dame, United States
    Active

Researchers

  • Principal investigator: Zorlutuna, Pinar — University of Notre Dame
  • Study coordinator: Zorlutuna, Pinar

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.